Download The CMBES Newsletter - Canadian Medical and Biological

CANADIAN MEDICAL AND BIOLOGICAL ENGINEERING SOCIETY
SOCIÉTÉ CANADIENNE DE GÉNIE BIOMÉDICAL
Winter 2011
Volume 44, Issue 1 rev1
ISSN: 1499-4089
The CMBES Newsletter
Message from the President of the CMBES,
Murat Firat, MSc.
Shaping CMBES’s
Directions
Inside this issue:
2
CMBEC34 Toronto
3-5
Cross Canada Review
Biomedical/Clinical Engineering Week
6
7-8
CMBEC 33 Review
9
Society Awards 2010
10
Membership
Canadian Pharmaceutical
Bar Coding Project
11-12
13
CMBEC 35 Halifax
CMBES Executive
President:
Vice President:
Murat Firat
Adrian Chan
Strategic
As announced earlier at
CMBEC33 in Vancouver, CMBES
Executive Committee members
have started working on the
“Strategic Plan 2011.” We are
refreshing our Society’s “vision
and mission,” and shaping new
strategic directions to navigate
CMBES through this rough and
challenging financial climate. The
plan has not been finalized yet ,
and I’m not in a position to report
the details, but I believe it would
be safe to hint that we are heading towards some of the most exciting times
of our Society. Believing that our strength lies
within our members, we will be investing our
energy in creating an environment of participation, collaboration and communication.
I beg and encourage each of you to participate. I do thank the Executive Committee
members and Dr. Bill Gentles for their efforts
and time that they have been putting in
CMBES Strategic Plan 2011. Details to be
reported at CMBEC34….
Past-President:
Dr. Donald Russel
Executive Secretary:
Pamela Wilson
Treasurer:
Martin Poulin
Membership:
Dennis Len
Professional Affairs:
Mike Capuano
Awards
Tim J Zakutney, MHSc, PEng, CCE
Publications:
Dr. Gnahoua Zoabli
Long Term Conference Planning :
Sarah Kelso
Newsletter Editors:
Dr. Gnahoua Zoabli
Pamela Wilson
CMBEC33 Vancouver (2010)
I’m having difficulty finding words to describe
CMBEC33: the amazing Continuing Education program, the colourful exhibit area, the
excellent scientific and clinical engineering
sessions, and last but not least, the perfect
banquet in the mesmerising Vancouver
Aquarium...
High-quality event topped up with high- quantity networking opportunities with colleagues...
CMBEC33 in Vancouver has taken its place
in the CMBES history as one of the best conferences (again!). Congratulations to Martin
Forbes, the Organizing Committee, volunteers, Pamela Wilson and the Willow Group
for doing an excellent job!
CMBEC34/FICCDAT – Toronto (2011)
Canadian Medical Biological Engineering Conference will be held, for the
second time, as a joint conference
within the Festival of Conferences on
Caregiving, Disabilities, Aging and
Technology (FICCDAT). Those who
participated in CMBEC30 would remember how successful the first FICCDAT was, so expect nothing less this
year. Many thanks to Dave Gretzinger
and the Organizing Committee of
CMBEC34; they have put together a
fabulous program to look forward to.
For details, please check out the second page.
CMBES and APIBQ Sign a Memorandum of
Understanding
As I hinted above, we are sailing towards exciting times. I’m proud to report on one of the many
ideas and actions that have come to life recently:
Last week CMBES and APIBQ (Association des
physiciens et ingénieurs biomédicaux du Québec) signed a memorandum of understanding
(MoU) to formalize the affiliation of both societies. The highlight of the MoU for the members of
each society is a generous reciprocal 50% membership discount. We believe both CMBES and
APIBQ members will benefit from this exciting
collaboration. Both societies will enjoy the collective energy produced by this momentum. Special
thanks to Gnahoua Zoabli who spearheaded this
initiative. Please check out the copy of the MoU
published at the website.
CMBES35 – Halifax 2012
Another hint for another upcoming exciting
event: CMBES and ACCES joint conference in
Halifax. Thanks to Sarah Kelso, Long-Term Conference Planning Chair. The planning is already
underway. More details will be announced in
June at the Toronto Conference. I hope to see
you all there.
Respectfully submitted.
Page 2
The CMBES Newsletter
CMBEC34: Toronto, Ontario
34th Canadian Medical and Biological Engineering Society Conference
Date: June 5-8, 2011 Location: Sheraton Centre Toronto Hotel,123 Queen
Street West in downtown Toronto
CMBES organizes an annual national medical and biological engineering conference in various cities across Canada. For 2011, the Society
will participate in FICCDAT (the Festival of International Conferences
on Caregiving, Disability, Aging and Technology).
Plan to join your colleagues for the premier event for Canadian Biomedical Engineering Professionals!
Visit
www.cmbes.ca
for further
information and
updates on
CMBEC34
The event will provide great opportunities for networking with peers, hearing the latest research, and learning about new technologies
and trends.
Registration is now available online at www.ficcdat.ca . Register early so you can take advantage of the discount!
We will join the other conferences of FICCDAT, providing opportunity to connect with other conferences, and open up CMBEC34 to a
wider audience. Your conference admission opens up the full slate of conferences to you:
•
•
•
•
•
RESNA (Rehabilitation Engineering and Assistive Technology Society of North America )
Advances in Neurorehabilitation
International Conference on Best Practices in Universal Design
Growing Older With A Disability
Caregiving in the 21st Century
There is a full slate of papers for the Scientific Program, and many seminars, workshops and roundtable discussions arranged for the
Clinical Engineering stream.
A continuing education program is also available for separate registration, including the following topics:
•
•
•
•
•
•
•
•
•
•
Show Me the Evidence: Develop Your Capacity to Make Informed Health Decisions
Medical Device Safety: FMEA and Root Cause Analysis
Convergence of IT and Medical Devices
Human Factors Assessment: Your Tool to Improve Patient Safety
Laser Fundamentals
New Equipment: You know what you want; now how do you get there?
Hospital Network and Information Systems
Renal Dialysis, basic and advanced techniques and technology
Preparing for the BMET Certification Exam
RFID/RTLS Technology within Hospital Environments
IEC 80001 standard for Medical Devices on Hospital Networks
Mark your
calendars!!
CMBEC34,
Toronto, ON
June 5-8, 2011
The organizing committee for this year’s conference is:
Dave Gretzinger - chair ; Mario Ramirez – clinical engineering program; Mike Capuano – clinical engineering program; Adrian Chan –
scientific program; Donald Russell – scientific program; Hubert DeBruin – scientific program; Chris Chovaz – continuing education; Tidimogo Gaamangwe – exhibits/sponsorship/marketting; Caroline Chen – students/volunteers; Martin Poulin – finance; Melanie Chayra
– logistics
For more information and conference details, please go to www.FICCDAT.ca .
Vo l u m e 4 4 , I s s u e 1
Page 3
A novel skin cancer detection technology pioneered in Canada
By Verisante Technology, Inc., Vancouver, BC
Leading dermatologists and cancer researchers from the British Columbia Cancer Agency and the University of British Columbia have developed a non‐invasive skin cancer detection device called the Verisante Aura that uses a light ray to determine whether a lesion is malignant or not. The technology is a breakthrough in early detection of skin cancer and can easily be used by any healthcare professional such as a physician’s assistant or a nurse to scan every mole on a patient’s body before a doctor reviews the results to decide whether a certain lesion should be biopsied or not. In the summer of 2010, Vancouver’s Verisante Technology, Inc., a medical device company, obtained the rights to the Verisante Aura. The Veri‐
sante Aura has been in development at the British Columbia Cancer Agency for more than six years and has been tested on approximately 1,000 lesions at the Skin Care Centre at the Vancouver General Hospital. Published preliminary clinical results have shown that the Verisante Aura caught every case of melanoma among the 274 lesions flagged for biopsy. The device will greatly aid doctors in assessing skin lesions and reducing patient wait times. While there are about 550 dermatologists in Can‐
ada, 1 in 7 (or approximately 5 million) Canadians will get skin cancer at some point during their lives. Currently if a patient has a lesion on their body, they have to undergo a biopsy, which is a surgical procedure to determine whether the lesion is malignant or not. However, this new technological approach, called “optical biopsy,” provides a number of practical benefits as listed below over existing detection methods. They include: Using a light ray, the device measures 21 chemical bio‐markers to scan a mole or lesion to determine skin cancer in under two seconds. It will allow for early and more accurate detection of skin cancer, which is the most treatable of all cancers when diagnosed early. It will avoid unnecessary biopsies and also detect more early‐stage skin cancers that would otherwise go unnoticed. It will reduce health‐care costs by enabling early diagnosis. It will enable patient comfort and convenience by reducing wait times and providing immediate diagnoses. The relatively low cost of the Verisante Aura makes it attractive to private health practices and larger healthcare facilities alike. Late last year, Verisante Technology, Inc. entered into an exclusive licensing agreement with the British Columbia Cancer Agency for rights to the lung cancer detection device. The device, termed the Verisante Core, has been clinically tested so far on more than 50 patients with excel‐
lent results. Both, the Verisante Aura and the Verisante Core share the same proprietary platform technology developed by the British Colum‐
bia Cancer Agency, but the operating software and probe technology are unique to each device. This platform technology is fully extensible to early detection systems for other cancers such as colon, cervical and gastrointestinal cancers. Neither the Verisante Aura nor the Verisante Core are approved for sale at this time, however, the company expects to launch the Verisante Aura in Canada in late 2011 subject to approval by Health Canada. For more information on the Verisante Aura and the Verisante Core, the product development team and for latest news, please visit: http://
www.verisante.com/. Thomas Braun, CEO of Verisante Technology, Inc. (left) with Dr. Haishan Zeng, one of the co-inventors of the Verisante technology
and a senior scientist, Integrative Oncology Department at the British Columbia Cancer Agency showing the Verisante technology for early cancer detection.
Page 4
The CMBES Newsletter
Revue ITBM-RBM pour publier en Français en génie
biomédical
Innovation et technologie
en biologie et médecine
Le 19 novembre 2010, le
Comité de bonnes pratiques
de l’APIBQ a reçu M. Gilbert
Farges, Animateur de la
rédaction du Guide des Bonnes Pratiques de l’Ingénierie
Biomédicale 2011. Lors de
cette rencontre, il a été question d’offrir aux francophones
œuvrant dans l’ingénierie/
physique médicale, l’opportunité de publier dans un journal francophone dédié au
génie biomédical. Les adhérents de l’APIBQ pourront
accéder aux publications de
ce journal et y soumettre
leurs articles. Les membres
francophones du CMBES y
sont conviés.
M. Gilbert Farges remettant une copie de la dernière
publication ITBM-RBM au président de l’APIBQ, M.
Gnahoua Zoabli, le 19 novembre 2010.
Un nouveau Guide des bonnes pratiques en 2011
ITBM-RBM
Un journal
francophone pour la
Sept associations professionnelles ont été impliquées dans la
réalisation du Guide des Bonnes
Pratiques de l’Ingénierie Biomédicale (GBPIB) - version 2011:
APIBQ : Association des Physiciens et
Ingénieurs Biomédicaux du Québec
(Québec) - Président : Gnahoua ZOABLI
AAMB : Association des Agents de Maintenance Biomédicale (France) - Président :
Christian BENDELE
ATGBM : Association des Technologues en
Génie Biomédical (Québec) - Présidente :
Michèle LAFONT
AFIB : Association Française des Ingénieurs
Biomédicaux (France) - Présidente : Martine
DECOUVELAERE
H 360 : Association nationale des cadres et
experts techniques hospitaliers (ex ANATH,
France) - Président : Eric MARTIN
AFITEB : Association Francophone Interhospitalière des Techniciens Biomédicaux
(Belgique) - Président : Gilbert ROMAIN
Pour faire suite aux travaux sur le
“Guide des Bonnes Pratiques de
l’Ingénierie Biomédicale – édition
ATD : Association des Techniciens de
Dialyse (France) - Président : Hubert
METAYER
2011”,
Maurice
Page
([email protected]) propose de travailler sur la conception d’une nouvelle Bonne
Pratique d’Activités Connexes
s’intitulant “Ingénierie biomédicale en radioprotection”.
Bien cordialement,
Gilbert Farges,
Projet Guide
Pratiques
Animateur du
des Bonnes
publication de vos
L’APIBQ fête ses 40 ans au Colloque du 10 juin 2011
travaux en genie
Hôpital de la Cité-de-la-Santé
biomédical
Auditorium RC.028
Colloque annuel APIBQ 2011
40e anniversaire de l’APIBQ
Vers une certification québécoise en génie clinique
10 juin 2011
1755, boul. René-Laennec
Laval (Québec) H7M 3L9
Téléphone : 450 668-1010
Pour vous inscrire:
http://www.apibq.org/colloque-2011
La certification en genie
clinique, thème central du
Colloque 2011, est aussi
d’actualité au CMBES et à
l’ATGBM. Les trois Associations sont en processus de
concertation pour une certification Nord-Américaine avec
l’American College of Clinical
Engineering (ACCE).
L’APIBQ élargit en 2010 son Membership au CMBES
et à l’AQPMC
Pour faciliter à ses membres
de s’impliquer dans les autres
Associations professionnelles
soeurs, l’Exéutif de l’APIBQ,
a decide que les membres en
règle du CMBES et de
l’AQPMC paient la moitié de
la cotisation pour leur membership. Cette mesure est
effective depuis le 25 novembre 2010. L’APIBQ s’attend
à ce que cette mesure soit
réciproque pour renforcer le
bénéfice aux membres communs desdites Associations
professionnelles.
Volume 44, Issue 1
Page 5
ITBM-RBM News to publish your biomedical engineering
work in French
On November 19, 2010, the
APIBQ Committee of good
practices received Mr. Gilbert
Farges, Coordinator of the
drafting of the 2011 edition of
Biomedical Guide of good
practices. At the time of this
meeting, there was some
discussion about offering to
the French-speaking people
working in medical physics or
clinical engineering, the opportunity of publishing in a
French-speaking newspaper
dedicated to clinical engineers and physicists. Active
members of APIBQ will be
able to reach this Elsevier
publication and submit their
articles for revision. The
French-speaking members of
the CMBES are invited there.
Mr. Gilbert Farges giving a copy of a recent publication of
ITBM-RBM News to the president of APIBQ, M. Gnahoua
Zoabli, on November 19, 2010.
Innovation and technology
in biology and medicine
A new edition of CE Standard of best practices in 2011
Seven professional associations were involved in the
realization of the 2011 edition
of Biomedical Guide of Good
Practices:
AAMB : Association des Agents de Maintenance Biomédicale (France) - Président :
Christian BENDELE
AFIB : Association Française des Ingénieurs
Biomédicaux (France) - Présidente : Martine
DECOUVELAERE
AFITEB : Association Francophone Interhospitalière des Techniciens Biomédicaux
(Belgique) - Président : Gilbert ROMAIN
APIBQ : Association des Physiciens et
Ingénieurs Biomédicaux du Québec
(Québec) - Président : Gnahoua ZOABLI
ATD : Association des Techniciens de
Dialyse (France) - Président : Hubert
METAYER
ATGBM : Association des Technologues en
Génie BioMédical (Québec) - Présidente :
Michèle LAFONT
H 360 : Association nationale des cadres et
experts techniques hospitaliers (ex ANATH,
France) - Président : Eric MARTIN
To make ongoing work on the
“Guide of the Good practices
in Biomedical Engineering -
2011 edition”, Maurice Page
([email protected])
proposes to work on the design of a new Good practice
of related activities being entitled “Biomedical Engineering
in protection against radiation”. Any CE expert willing to
contribute to this work is invited to contact directly Mr.
Page.
A francophone
Enjoy APIBQ 40th anniversary at June 10 conference
Cité-de-la-Santé Hospital
Auditorium RC.028
Annual Conference
1755, boul. René-Laennec
APIBQ 2011
Laval (Québec) H7M 3L9
40th anniversary
Phone : 450 668-1010
Towards a Quebec certification
in
Clinical Engineering
For information/registration:
Promote certification in Clinical
engineering, the central theme of
the 2011 Conference, is also
shared with CMBES and ATGBM.
The three Associations are in a
dialogue process for an unified
Nord-American certification with
the American College of Clinical
Engineering.
http://www.apibq.org/colloque-2011
June 10, 2011
Since November 2010, APIBQ Membership is extended to
CMBES and AQPMC
To facilitate the implication
of common members from
other CE professional associations, the Exeutive board
of APIBQ has decided that
the active members of the
CMBES and the AQPMC
will pay half of the their
APIBQ membership fee. This
measure is effective since
November 25, 2010.
ITBM-RBM
The APIBQ Executive board
expects a reciprocity to reinforce the benefits of the common members of these professional associations.
journal for the
publication of your
Biomedical
Engineering work
Page 6
Vo l u m e 4 4 , I s s u e 1
Biomedical/Clinical Engineering
Appreciation Week
National Biomedical/Clinical Engineering Appreciation Week
This year Biomed/CE National Appreciation Week takes place May 22 - 28,
2011. We encourage all organization
departments to celebrate.
This can be done in the following ways:
• set up a booth and/or display with photos and information; • hold an open
house; • contact your local TV affiliate; •
deliver a presentation; • celebrate at a
department meeting; • present a local
high school for awareness; and, • hold
nominations for a practice/excellence
award.
Links:
For information on a career as a Biomedical Equipment Technician go to:
http://www.aami.org/student/index.html
For AAMI information on NBCEAW, go
to:
http://www.aami.org/tmcconnect/
promoting.html
Documents:
2011 sample material coming soon!
by Mike Capuano CBET
CMBES Chair, Professional Affairs
New Video: Becoming a Biomedical
Equipment Technician
http://www.vimeo.com/9712136
Click here to listen to a radio interview
with AAMI/TMC representatives on Biomedical/Clinical Engineering.
(http://www.aami.org/
news/2009/052709.interview.html)
Page 7
The CMBES Newsletter
A great conference: CMBEC33 Vancouver
Organizing Committee: L‐R, Martin Forbes (Conference Chair), Pamela Wilson (Secretariat‐ Willow Group), Kyle Eckhardt (Clinical Engineering), Maria Fredriksson (Local Arrangements), Martin Poulin (Treasurer), Dr Ezra Kwok (Academic Co Chair), Gordon Jasechko (Continuing Educ), Kay Henke (Clin Eng Co ‐Chair), Andrew Ibey (Clin Eng Co Chair), Gord McConnell (Local Arrangements) Missing, Judy Findlay (Med Devices Chair), Nancy Paris (Exhibits Chair), Dr Andrew Rawicz (Academic Co‐chair) Conference chair: Martin Forbes, P.Eng., MBA
Academic chairs: Dr Andrew Rawicz and Dr Ezra Kwok
Page 8
The CMBES Newsletter
More from CMBEC33 Vancouver
A great
conference !
Vo l u m e 4 4 , I s s u e 1
Page 9
Message from the Awards Committee
Chairman - Tim J Zakutney, MHSc, PEng, CCE
Society Awards
Outstanding Canadian Biomedical Engineer
This CMBES Award was established in 1989 and is presented to a Canadian biomedical engineer
who has made outstanding contributions in the field of biomedical engineering. Such achievements
can be in the form of scientific or technical developments as well as a broad-spectrum of areas such
as leadership, service and organizational skills that contributed to the improvement of health care
delivery in Canada, or prominence in organizations concerned with biomedical engineering at the
national or international level. Achievements for consideration shall have taken place during the
three years immediately preceding the award year.
A potential candidate must be a professional engineer who is a member in good standing of CMBES
and actively engaged in biomedical engineering activity in Canada. The award consists of a certificate, which will be presented annually at the CMBES Conference. This award will be made only if a worthy candidate is proposed..
Outstanding Canadian BMET
This CMBES Award was established in 1982 and is presented to a Canadian BMET to recognize excellence in the field of
biomedical engineering technology. This award is presented to a technician or technologist who has distinguished him or herself in one or more of the following areas:
scientific or technical abilities
exceptional service and/or technical skills
outstanding contributions to the improvement of health care technology
Notoriety in the profession of biomedical engineering technology at the national and/or international level.
A nominee must be a certified BMET or eligible for certification as a BMET and must be a member in good standing of the
Society. The nominee must be actively engaged in some form of biomedical engineering technology in Canada. Achievements
for consideration shall have taken place during the three years immediately preceding the award year. The award will be made
only if a worthy candidate is proposed and will consist of a certificate that will be presented annually at the CMBES Conference.
Early Career Achievement Award
This CMBES Award, established in 2007, is intended to recognize young professionals who have demonstrated outstanding
performance and achievement in the early stages of their career. To be eligible for this award a candidate must be a CMBES
member who graduated from a College or University program related to biomedical engineering in the broadest sense and has
been working in the field for a maximum of 5 years. This award will be presented to an individual who has consistently demonstrated exceptional skills in such areas as: client services, technical performance, sophisticated scientific or technology
development.
Special Membership Recognition/Honours
The CMBES Awards Committee is seeking nominations of members to whom Special Status should be awarded. Special
Membership status is awarded only to distinguished individuals who have made significant contributions to the profession of
biomedical engineering and to the Society in particular. Nominations for Special Membership status are being sought in the
following three categories: Fellow, Emeritus, Honorary Member.
Society Awards – Special Membership Recognition/Honours
The CMBES Awards Committee is seeking nominations of members eligible and deserving of the societies awards.
For more information on the Awards or to nominate a deserving individual click here.
Page 10
Vo l u m e 4 4 , I s s u e 1
CMBES membership update
Total Membership
New Members
Renewals
Regular Members
Fellow
Emeritus
Honorary
Retired
Corporate
New Members (Student)
Renewals (Student)
Student Members
Student Institutional
General Membership Statistics - as of February 17 2011
2011
2010
2009
149
287
269
Pending
Active
11
4
65
48
28
77
138
161
39
81
203
209
2
0
0
0
1
36
0
2
2
2
0
51
4
6
2
6
12
11
16
27
14
13
115
6
6
2
8
66
65
19
84
66
18
209
5
8
4
6
43
41
19
60
50
10
2008
243
123
5
10
5
8
45
CMBES-APIBQ Memorandum of understanding
The complete text of CMBES-APIBQ Memorandum of Understanding will be available online
in the members-only section of CMBES website.
34
13
Vo l u m e 4 4 , I s s u e 1
Page 11
The Canadian Pharmaceutical Bar Coding Project:
Automated Identification of Medications to Increase Patient Safety
Institute for Safe Medication Practices Canada®
The Canadian Pharmaceutical Bar Coding Project is a pan‐Canadian safety collaborative. Its primary objective establishes a consistent method of encoding Canadian commercial pharmaceutical product packages with essential product identifiers, using a global automated identification (bar code) standard. Such encoded data elements, and the accompanying standard product descriptors, better enables the design of future technologies by technology providers that would improve medication identification accuracy and documentation, patient safety functionality, and thereby reduce preventable errors and related morbidities. We have endorsed the consistent use of GS1 global “Automated Identification” (AI) standard at every step of the medication process within both institutional and community care: from the pharmaceutical manufacturer, through the supply chain, local purchasing and inventory con‐
trol, medication distribution, compounding and dispensing prescriptions, and including the patient dose administration step. The selected stan‐
dard defines the method of product identification (encoding), allowable barcode symbologies, and rules for manufactures when packaging and labelling their products. Though commonly referred to as ‘bar coding’, the global AI standard encompass other encoding methods such as radio‐frequency identification methods (RFID). The application of the GS1 standards to medications marketed in Canada is outlined in the Joint Technical Statement on Phar‐
maceutical Automated Identification and Product Database Requirements (JTS), issued in February 2010 and developed by a 34 member Technical Task Force, comprised of for‐profit and not‐for‐profit members from six Canadian healthcare sectors. The Canadian statement is consistent with activities of many global health jurisdictions; each developing global alignment strategies for medi‐
cations and other health products. Other organizations partnered with the Project include the Public Health Agency of Canada, Pharmaceutical companies and their representa‐
tive organizations, national Group Purchasing Organizations, Canada Health Infoway, major Canadian health organizations, and retail pharmacy chains. Like CMBES, leading healthcare practice organizations such as provincial Health Quality Councils, the Health Council of Canada, the Canadian Medical Association, the Ontario Hospital Association, the Canadian Healthcare Association, and others have endorsed this initiative. Detailed project information, the Joint Technical Statement, and supporters can be found on our project pages at the following web link: ( http://www.ismp‐canada.org/index.htm ). The GS1 Canada website provides advanced technical information regarding its global Automated Identification standard: ( http://www.gs1ca.org/home.asp ). Page 12
Vo l u m e 4 4 , I s s u e 1
The Canadian Pharmaceutical Bar Coding Project:
Automated Identification of Medications to Increase Patient Safety
The Use of Automated Identification and Data Capture (AIDC) Standards for Canadian Pharmaceutical Product Identification and Documentation November 18, 2010. The Canadian Medical and Biological Engineering Society (CMBES) supports advancements in the theory and prac‐
tice of medical device technology. As such, the members of our Society are involved in the acquisition and practice integration of tech‐
nologies which improve the safety and efficiencies of healthcare processes. Our Society endorses the Canadian Pharmaceutical Bar Code Project, a pan‐Canadian multi‐sector initiative to adopt national Automated Identification and Data Capture (AIDC) standards for the accurate identification and documentation of pharmaceutical products in healthcare practices. We support the selection of the global GS1 AIDC standards as a basis for establishing this national strategy. CMBES also recognizes the need for industry to develop aligned software and technical systems that will assist all health practitioners in scanning, patient and product identification, and related quality documentation while performing important patient care activities. We therefore encourage technology providers, health organizations and practitioners alike to actively support these collaborative efforts to improve medication and patient safety for Canadians. Murat Firat
Adrian Chan
Martin Poulin
Dennis Len
Gnahoua Zoabli
Mike Capuano
President
Vice-President
Treasurer
Membership
Publications
Professional Affairs
Tim J Zakutney Donald Russell
Awards
Past-President
Vo l u m e 4 4 , I s s u e 1
CMBEC35 HALIFAX
Interested in joining the Organizing
Committee,
apply at [email protected].
You are invited to send your best
pics of CMBEC34 at
[email protected]
Page 13